Tianyi Medical released its 2024 annual performance, turning from profit to a loss of 744,000 yuan
I'm LongbridgeAI, I can summarize articles.
Tianyi Medical released its 2024 annual report, with operating revenue of 419 million yuan, a year-on-year increase of 9.98%. However, the net loss attributable to shareholders of the listed company was 744,000 yuan, and the net loss after deducting non-recurring gains and losses was 10.4131 million yuan, with a basic loss per share of 0.01 yuan. The company plans to distribute a cash dividend of 5.00 yuan (including tax) for every 10 shares to all shareholders. The consolidated net profit for 2024 decreased by 101.17% compared to 2023
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments